Literature DB >> 12903682

Effect of growth factors on hyaluronan production by canine vocal fold fibroblasts.

Shigeru Hirano1, Diane M Bless, Dennis Heisey, Charles N Ford.   

Abstract

Hyaluronan (HYA) is considered to be a crucial factor in scarless wound healing and in maintaining tissue viscosity of the vocal fold lamina propria. In this study focusing on the effects of growth factors, we examined how HYA is produced and controlled in canine cultured vocal fold fibroblasts. Fibroblasts were taken from the lamina propria of the vocal folds of 8 dogs and cultured with and without growth factors. The production of HYA in the supernatant culture was quantitatively examined by enzyme-linked immunosorbent assay. Hepatocyte growth factor, epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta1 all stimulated HYA synthesis from vocal fold fibroblasts. These effects differed with the concentration of growth factors and the incubation period. We also examined how frequently the growth factors had to be administered in order to maintain appropriate levels of HYA. A single administration was sufficient to maintain appropriate HYA levels for at least 7 days. The present studies have demonstrated positive effects of growth factors in stimulating HYA production. Further in vivo study is needed to clarify the usefulness of these growth factors in the management of vocal fold scarring.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12903682     DOI: 10.1177/000348940311200708

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  22 in total

1.  Biosimulation of inflammation and healing in surgically injured vocal folds.

Authors:  Nicole Y K Li; Yoram Vodovotz; Patricia A Hebda; Katherine Verdolini Abbott
Journal:  Ann Otol Rhinol Laryngol       Date:  2010-06       Impact factor: 1.547

Review 2.  The unsolved chapter of vocal fold scars and how tissue engineering could help us solve the problem.

Authors:  M Graupp; S Bachna-Rotter; C Gerstenberger; G Friedrich; E Fröhlich-Sorger; K Kiesler; M Gugatschka
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-25       Impact factor: 2.503

3.  Liquid-type non-thermal atmospheric plasma ameliorates vocal fold scarring by modulating vocal fold fibroblast.

Authors:  Ho-Ryun Won; Eun Hye Song; Jong Eun Won; Hye Young Lee; Sung Un Kang; Yoo Seob Shin; Chul-Ho Kim
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-14

4.  Epidermal growth factor mediated healing in stem cell-derived vocal fold mucosa.

Authors:  Liliana Palencia; Amritava Das; Sean P Palecek; Susan L Thibeault; Ciara Leydon
Journal:  J Surg Res       Date:  2015-03-05       Impact factor: 2.192

5.  [Treatment of glottal gap].

Authors:  S Voigt-Zimmermann; C Arens
Journal:  HNO       Date:  2013-02       Impact factor: 1.284

Review 6.  Vocal fold scars: current concepts and future directions. Consensus report of the Phonosurgery Committee of the European Laryngological Society.

Authors:  G Friedrich; F G Dikkers; C Arens; M Remacle; M Hess; A Giovanni; S Duflo; A Hantzakos; V Bachy; M Gugatschka
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-21       Impact factor: 2.503

7.  Functional morphology of the sound-generating labia in the syrinx of two songbird species.

Authors:  Tobias Riede; Franz Goller
Journal:  J Anat       Date:  2009-11-09       Impact factor: 2.610

Review 8.  Clinical applications of mesenchymal stem cells in laryngotracheal reconstruction.

Authors:  Summer Hanson; Susan L Thibeault; Peiman Hematti
Journal:  Curr Stem Cell Res Ther       Date:  2010-09       Impact factor: 3.828

9.  A method for identification of vocal fold lamina propria fibroblasts in culture.

Authors:  Susan L Thibeault; Wenhua Li; Stephanie Bartley
Journal:  Otolaryngol Head Neck Surg       Date:  2008-12       Impact factor: 3.497

10.  Advances in biomimetic regeneration of elastic matrix structures.

Authors:  Balakrishnan Sivaraman; Chris A Bashur; Anand Ramamurthi
Journal:  Drug Deliv Transl Res       Date:  2012-10       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.